NCT01412177View on ClinicalTrials.gov

OTO-104 for the Treatment of Meniere's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Meniere's Disease
Interventions
DRUG

OTO-104

Single intratympanic injection of 12 mg OTO-104

DRUG

Placebo

Single intratympanic injection of placebo

Trial Locations (2)

45219

UC Health Otolaryngology - Head and Neck Surgery, Cincinnati

Unknown

Many sites in US and Canada. Refer to the contact info listed below., San Diego

Sponsors

Lead Sponsor

Otonomy, Inc.
All Listed Sponsors
lead

Otonomy, Inc.

INDUSTRY